Lenny Van Steenhuyse is principal at Droia Ventures, a venture capital fund dedicated to oncology & genetic disease therapeutics. At Droia, Lenny focusses on late preclinical/early clinical investments spanning both private and public companies. He has a dual background in biotechnology & finance and started his career at Turnstone Communications managing communication consultancy projects for various stakeholders in the biotech industry. He later spent 5 years in biotech public markets at KBC Securities, both as equity analyst covering stock-listed biotech companies and as associate director corporate finance structuring financings in the biotech sector.
